Obesity and Functioning Among Individuals with Chronic Obstructive Pulmonary Disease (COPD)

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 13, Issue 3, 2016, Pages 352-359

  Katz, Patricia ^a   Iribarren, Carlos ^b   Sanchez, Gabriela ^b   Blanc, Paul D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

6 minute walk distance; BMI; COPD; functional decline; functioning; obesity

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHORT PHYSICAL PERFORMANCE BATTERY; SIX MINUTE WALK DISTANCE; SLEEP DISORDERED BREATHING; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; WALK TEST;

AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; WALK TEST;

EID: 84950133732     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2015.1087991     Document Type: Article

References (40)

1. R.Sturm, J.Ringel, T.Andreyeva. Increasing obesity rates and disability trends. Health Aff 2004; 23(2):199–205.
2. C.Landbo, E.Prescott, P.Lange, J.Vestbo, T.Almdal. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(6):1856–1861.
3. F.Franssen, D.O'Donnell, G.Goossens, E.Blaak, A.Schols. Obesity and the lung: 5.Obesity and COPD. Thorax 2008; 63(12):1110–1117.
4. M.Eisner, P.D.Blanc, S.Sidney, E.H.Yelin, P.Lathon, P.P.Katz, I.Tolstykh, L.Ackerson, C.Iribarren. Body composition and functional limitation in COPD. Respir Res 2007; 8:7.
5. N.Leone, D.Courbon, F.Thomas, K.Bean, B.Jego, B.Leynaert, L.Guize, M.Zureik. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 2009;179(6):509–516.
6. D.O'Donnell, C.Ciavaglia, J.Neder. When obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequences. Ann Am Thorac Soc 2014;11(4):635–644.
7. A.Sood. Obesity, adipokines, and lung disease. J Appl Phsyiol 2010; 108(3):744–753.
8. F.Sava, L.Laviolette, S.Bernard, M.Breton, J.Bourbeau, F.Maltais. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med 2010; 10:55.
9. R.Galesanu, S.Bernard, K.Marquis, Y.Lacasse, P.Poirier, J.Bourbeau, F.Maltais. Obesity and chronic obstructive pulmonary disease: Is fatter really better? Can Respir J 2014; 21(5):297–301.
10. N.ten Hacken Physical inactivity and obesity: relation to asthma and chronic obstructive pulmonary disease? Proc Am Thorac Soc 2009; 6(8):663–667.
11. M.Eisner, C.Iribarren, P.Blanc, E.Yelin, L.Ackerson, N.Byl, T.Omachi, S.Sidney, P.Katz. Development of disability in chronic obstructive pulmonary disease: beyond lung function. Thorax 2011; 66(2):108–114.
12. B.Celli, C.Cote, J.Marin, C.Casanova, M.de Oca, R.Mendez, V.Plata, H.Cabral. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10):1005–1012.
13. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization, 2000.
14. American Thoracic Society. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166(1):111–117.
15. J.Guralnik, E.Simonsick, L.Ferrucci, R.Glynn, L.Berkman, D.Blazer, P.Scherr, R.Wallace. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol: Med Sci 1994; 49(2):M85–M94.
16. M.Eisner, P.Blanc, E.Yelin, S.Sidney, P.Katz, L.Ackerson, P.Lathon, I.Tolstykh, T.Omachi, N.Byl, C.Iribarren. COPD as a systemic disease: impact on physical functional limitations. Am J Med 2008;121(9):789–796.
17. S.Patel, D.Mohan, Y.Andersson, M.Baz, S.Kon, J.Canavan, S.Jackson, A.Clark, N.Hopkinson, S.Natanek, P.Kemp, P.Bruijnzeel, W.Man, M.Polkey. Phenotypic characteristics associated with reduced Short Physical Performance Battery score in COPD. Chest 2014;145(5):1016–1024.
18. American Thoracic Society, European Respiratory Society. Standardization of spirometry. Euro Respir J 2005; 26(2):319–338.
19. J.L.Hankinson, J.R.Odencrantz, K.B.Fedan. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159(1):179–187.
20. J.Bestall, E.Paul, R.Garrod, R.Garnham, P.Jones, J.Wedzicha. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54(7):581–586.
21. G.Norman, J.Sloan, K.Wyrwich. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–592.
22. B.Make How can we assess outcomes of clinical trials: the MCID approach. COPD 2007; 4(3):191–194.
23. S.Perera, S.Mody, R.Woodman, S.Studenski. Meaningful change and responsiveness in common physical peformance measures in older adults. J Am Geriatr Soc 2006; 54(5):743–749.
24. R.Wise, C.Brown. Minimal clinically important difference in the six-minute walk test and the incremental shuttle walking test. COPD 2005; 2(1):125–129.
25. M.Polkey, M.Spruit, L.Edwards, M.Watkins, V.Pinto-Plata, J.Vestbo, P.Calverley, R.Tal-Singer, A.Agusti, P.Bakke, H.Coxson, D.Lomas, W.MacNee, S.Rennard, E.Silverman, B.Miller, C.Crim, J.Yates, E.Wouters, B.Celli. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Resp Crit Care Med 2013; 187(4):382–386.
26. A.Schols, R.Broekhuizen, C.Weling-Scheepers, E.Wouters. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82(1):53–59.
27. D.Okorodudu, M.Jumean, V.Montori, A.Romero-Corral, V.-J.Somers, J, P.Erwin, F.Lopez-Jimenez. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes 2010; 34(10):791–799.
28. J.Vestbo, E.Prescott, T.Almdal, M.Dahl, B.Nordestgaard, T.Andersen, T.Sørensen, P.Lange. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample. Am J Respir Crit Care Med 2006; 173(1):79–83.
29. S.Kim, Y.Kang, J.Jung, M.Park, Y.Kim, S.Kim, J.Chang, E.Kim. Body mass index and fat free mass index in obstructive lung disease in Korea. Int J Tuberc Lung Dis 2014; 18(1):102–108.
30. F.Maltais Body composition in COPD: looking beyond BMI. Int J Tuberc Lung Dis 2014; 18(1):3–4.
31. C.van de Bool, R.EPAR, F.Franssen, W.EFMW, A.Schols. Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD. Eur Respir J 2015;46(2):336–345.
32. F.Franssen Overweight and obesity are risk factors for COPD misdiagnosis and overtreatment. Chest 2014; 146(6):1426–1428.
33. N.Krieger Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Publ Health 1992; 82(5):703–710.
34. L.Steuten, E.Creutzenbert, H.Vrijhoef, E.Wouters. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J 2006; 15(2):84–91.
35. M.Montes de Oca, Tálamo C., Perez-Padilla R., Jardim J., Muino A., Lopez M., Valdiva G., Pertuzé J., Moreno D., Halbert R., Menezes A., PLATINO Team. Chronic obstructive pulmonary disease and body mass index in five Latin American cities: the PLATINO study. Respir Med 2008; 102(5):642–650.
36. N.Vozoris, D.O'Donnell. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J 2012; 19(3):e18–e24.
37. H.Vincent, K.Vincent, K.Lamb. Obesity and mobility disability in the older adult. Obesity Rev 2010; 11(8):568–579.
38. J.Batsis, A.Zbehlik, E.Scherer, L.Barre, S.Bartels. Normal weight with central obesity, physical activity, and functional decline: data from the Osteoarthritis Iniative. J Am Geriatr Soc 2015; 63(8):1552–1560.
39. F.Artaud, A.Singh-Manoux, A.Dugravot, B.Tavernier, C.Tzourio, A.Elbaz. Body mass index trajectories and functional decline in older adults: Three-City Dijon cohort study. Eur J Epidemiol 2015 Apr 9 [Epub ahead of print].
40. N.Greening, R.Evans, J.Williams, R.Green, S.Singh, M.Steiner. Does body mass index influence the outcomes of a walking-based pulmonary rehabilitation programme in COPD? Chron Respir Dis 2012; 9(2):99–106.